Orange Book Blog

American Conference Institute is holding its fourth annual "Pharmaceutical Antitrust" conference on May 20-21, in National Harbor, Maryland.

According to ACI, at the conference, "leading in-house pharmaceutical counsel, government regulators, and expert attorneys will provide practical advice on how to successfully tackle the most complex antitrust issues facing brand-name and generic pharmaceutical companies."

Several of the presentations look particularly interesting:

• A Keynote Address by Stephen Calkins, Former General Counsel of the Federal Trade Commission
• "Assessing What the Authorized Generic Study and Report on Intellectual Property Collectively Mean for the Pharmaceutical Industry"
• "The Law of Hatch-Waxman Patent Infringement Settlements and Where it is Going"
• "Congressional Action on Pharmaceutical Patent Settlements: Pending Legislation and Strategies to Employ"
• "Life Cycle Management Strategies for Protecting Your Product and Reducing Antitrust Exposure"
• "DOJ Perspective on Recent Developments in Antitrust and IP Law"
• A Keynote Address by Jon Leibowitz, Commissioner, Federal Trade Commission

The conference also features a Master Class on May 2: "Navigating the Pharmaceutical Merger Process."

For more information or to register, please visit the conference website.